Outcome of Board meeting dated 29th July, 2025 is attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Hamps Bio Ltd met on July 29, 2025 and approved several key items. The most significant decision was recommending a 1:1 bonus share issue, meaning one bonus equity share of Rs. 10 each for every one share held, doubling the paid-up share capital from Rs. 4.35 crore (43.56 lakh shares) to Rs. 8.71 crore (87.12 lakh shares), funded from free reserves (Rs. 49.88 lakhs) and securities premium (Rs. 394.57 lakhs). The Board also approved an increase in authorised share capital along with consequential amendments to the Memorandum of Association. Additionally, the Board approved the notice for the 18th Annual General Meeting to be held on August 29, 2025, along with the Board's Report and draft Annual Report for FY ended March 31, 2025. A retiring director, Mr. Shrenikkumar Mountkumar Shah, was re-appointed by rotation, and the Secretarial Audit report was noted.
The 1:1 bonus issue is a positive signal for shareholders, effectively doubling their share count without additional investment, though the share price typically adjusts downward proportionally post-ex-date. The capital increase signals growth plans. Bonus shares are expected to be credited by September 28, 2025, pending shareholder approval at the upcoming AGM.